SI-BONE receives FDA clearance, fully launches patented iFuse-3D Implant: 6 points

Megan Wood -   Print  |

SI-BONE received FDA clearance for its iFuse-3D Implant.

Here are six points:

 

1. The company is also initiating a full U.S. commercial launch of the implant.

 

2. The iFuse-3D Implant is the first 3-D-printed titanium implant for SI joint use.

 

3. The company leveraged proprietary 3-D-printing technology to create a patented fenestrated design and porous surface to mirror cancellous bone's trabecular structure.

 

4. The implant promotes bone ongrowth, ingrowth and through growth, demonstrated in a study published in the International Journal of Spine Surgery.

5. More than 50 peer-reviewed publications support the iFuse Implant's triangular titanium design. The iFuse Implant system offers a minimally invasive solution to fuse the SI joint.

 

6. The iFuse-3D features 250 percent greater surface area than the iFuse Implant.

 

More articles on MIS:
MIS spine market to grow at 14.7% CAGR through 2022: 10 market observations
Blue Cross and Blue Shield of Vermont adds minimally invasive SI joint fusion coverage for 200k members: 4 key notes
Minimally invasive vs. open decompression for lumbar spinal stenosis: 5 key notes

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers